Hypermethylation of CpG Islands in Primary and Metastatic Human Prostate Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-03-3972
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

GSTP1 CpG Island Hypermethylation Is Responsible for the Absence of GSTP1 Expression in Human Prostate Cancer Cells

American Journal of Pathology
Forensic MedicinePathology
2001English

Differential Targets of CpG Island Hypermethylation in Primary and Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Journal of Medical Genetics
Genetics
2003English

Epigenetic Inactivation of EGFR by CpG Island Hypermethylation in Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2006English

CpG Island Hypermethylation-Associated Silencing of Non-Coding RNAs Transcribed From Ultraconserved Regions in Human Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2010English

Overall Survival and Second Primary Malignancies in Men With Metastatic Prostate Cancer

PLoS ONE
Multidisciplinary
2020English

Correction: CpG Island Hypermethylation-Associated Silencing of Non-Coding RNAs Transcribed From Ultraconserved Regions in Human Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2018English

CpG Islands

Genome Biology
2002English

CpG Hypermethylation of Collagen Type I Α 2 Contributes to Proliferation and Migration Activity of Human Bladder Cancer

International Journal of Oncology
Cancer ResearchOncology
2009English

Correlating CpG Islands, Motifs, and Sequence Variants in Human Chromosome 21

2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy